At a glance
ClinicalIndex Comparison RecordN/ACompleted· 38 enrolled
Drug / intervention
A novel digital health devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing a Novel Virtual Environment That Primes Individuals Living With AD/ADRD to Accomplish Activities of Daily Living
In Brief
A clinical study evaluating A novel digital health device for Dementia and 2 related conditions. Completed, enrolled 38 participants across 2 sites.
Detailed Summary
This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDementia, Alzheimer Disease, Neurodegenerative Diseases
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJun 2022
First PostedJun 2022
Primary CompletionAug 2023
Study CompletionOct 2023
TodayJul 2026
First PostedJun 14, 2022
Enrollment StartJun 9, 2022
Primary CompletionAug 30, 2023
Study CompletionOct 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.0 years ago
Interventions
A novel digital health devicedevice
A videogame-generated virtual world designed for the AD/ADRD care dyad.